Angusta 25 Mikrogramm Tabletten
The marketing authorisation holder informed its customers on June 24, 2022, that due to contamination the mentioned medicinal product is recalled as a precautionary measure. The risk of the contamination has been determined to be low.
|Name of the medicinal product||Angusta 25 Mikrogramm Tabletten|
|Marketing authorisation number(s)||140316|
|Marketing authorisation holder||Norgine B.V.|
|Batch number(s)||Batch, Expiry Date|
|Classification of the recall||2|
|Depth of recall||Pharmacies|